Schrodinger (NASDAQ:SDGR) Azioni

Schrodinger

Schrodinger Inc is a healthcare-based software company. Its operating segments are Software and Drug discovery. Through the Software segment, the company is focused on selling software to transform drug discovery across the life sciences industry and customers in materials science industries. In the Drug discovery segment, it is engaged in generating revenue from a portfolio of preclinical and clinical programs, internally and through collaborations. It generates revenue from the sales of software solutions and from research funding and milestone payments from its drug discovery collaborations.

Schrodinger Inc

Press Releases

Schrödinger Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)

Schrödinger to Announce Fourth Quarter and Full-Year 2024 Financial Results on February 26

Schrödinger to Participate in Upcoming Investor Conferences

Schrödinger Reports Strong Fourth Quarter and Full-Year 2024 Financial Results

Schrödinger Expands Board of Directors with Appointment of Bridget van Kralingen

Schrödinger to Present Preclinical Data at AACR Annual Meeting

Schrödinger's Statement Regarding FDA Plan to Phase Out Animal Testing Requirement for Monoclonal Antibodies and Other Drugs

SDGR

Firefly Neuroscience, Inc. - Common Stock

Firefly Neuroscience

American Well Corporation Class A Common Stock

American Well

CareCloud

Certara

Claritev Corporation Class A Common Stock

Claritev

Definitive Healthcare Corp. - Class A Common Stock

Definitive Healthcare

Doximity

DarioHealth

Evolent Health

Forian

GoodRx Holdings, Inc. - Class A Common Stock

GoodRx Holdings

Health Catalyst

HealthStream

icad

LifeMD

OptimizeRx

Phreesia

Pheton Holdings Ltd - Class A Ordinary Shares

Pheton Holdings

Simulations Plus

Sophia Genetics

TruBridge

Teladoc Health

Veeva Systems

VSee Health

Waystar Holding

Keybanc

Piper Sandler

BMO Capital

Morgan Stanley

Leerink Partners

Comments

Schrodinger

Notizie

PARTNER/COLLABORATORE

BENZINGA NEL MONDO